Jiangsu Recbio Technology Stock Down 10% But Insiders Still In CN¥638k Profit
Insiders who bought Jiangsu Recbio Technology Co., Ltd. (HKG:2179) stock lover the last 12 months are probably not as affected by last week’s 10% loss. After taking the recent loss into consideration, the CN¥2.87m worth of stock they bought is now worth CN¥3.50m, indicating that their investment yielded a positive return.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
The Last 12 Months Of Insider Transactions At Jiangsu Recbio Technology
The Non-Executive Chairman Haoyu Xu made the biggest insider purchase in the last 12 months. That single transaction was for HK$1.7m worth of shares at a price of HK$3.58 each. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of HK$4.40. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
Haoyu Xu bought 796.50k shares over the last 12 months at an average price of HK$3.60. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
See our latest analysis for Jiangsu Recbio Technology
Jiangsu Recbio Technology is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership Of Jiangsu Recbio Technology
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Insiders own 8.6% of Jiangsu Recbio Technology shares, worth about HK$232m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
So What Does This Data Suggest About Jiangsu Recbio Technology Insiders?
The fact that there have been no Jiangsu Recbio Technology insider transactions recently certainly doesn't bother us. On a brighter note, the transactions over the last year are encouraging. With high insider ownership and encouraging transactions, it seems like Jiangsu Recbio Technology insiders think the business has merit. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 3 warning signs for Jiangsu Recbio Technology and we suggest you have a look.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.